190 related articles for article (PubMed ID: 37822394)
1. Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.
Yadav V; Mendiratta V; Agrawal A; Bisherwal K; Singh R; Meena AK
Indian J Dermatol; 2023; 68(4):377-384. PubMed ID: 37822394
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic Fatty Liver Disease Among Iraqi Patients With Psoriasis: A Case-Control Study.
Dhaher SA; Hilfi NZ; Abdullah MA
Cureus; 2024 Apr; 16(4):e57487. PubMed ID: 38707119
[TBL] [Abstract][Full Text] [Related]
3. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease.
Abedini R; Salehi M; Lajevardi V; Beygi S
Clin Exp Dermatol; 2015 Oct; 40(7):722-7. PubMed ID: 25958919
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Chronic Plaque Psoriasis and Nonalcoholic Fatty Liver Disease in Indian Patients: Results of a Pilot Study.
Mahajan VK; Chauhan NS; Rana BS; Mehta KS; Hooda S; Chauhan PS; Kukreja A
J Clin Exp Hepatol; 2022; 12(3):785-792. PubMed ID: 35677516
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-calorie diet on psoriasis severity index, triglycerides, liver enzymes, and quality of life in psoriatic patients with non-alcoholic fatty liver disease.
Ismail AMA; Saad AE; Draz RS
Reumatologia; 2023; 61(2):116-122. PubMed ID: 37223373
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
Gisondi P; Targher G; Zoppini G; Girolomoni G
J Hepatol; 2009 Oct; 51(4):758-64. PubMed ID: 19560226
[TBL] [Abstract][Full Text] [Related]
7. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
8. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
10. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
12. The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.
Campanati A; Ganzetti G; Di Sario A; Damiani A; Sandroni L; Rosa L; Benedetti A; Offidani A
J Gastroenterol; 2013 Jul; 48(7):839-46. PubMed ID: 23065020
[TBL] [Abstract][Full Text] [Related]
13. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.
Bajaj S; Nigam P; Luthra A; Pandey RM; Kondal D; Bhatt SP; Wasir JS; Misra A
Indian J Med Res; 2009 Mar; 129(3):285-92. PubMed ID: 19491421
[TBL] [Abstract][Full Text] [Related]
14. Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors.
Pattnaik K; Bhuyan P; Singh A; Singh SP; Nath P; Kar S; Misra B; Rath J
J Clin Exp Hepatol; 2018 Dec; 8(4):367-374. PubMed ID: 30563997
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.
Nigam P; Bhatt SP; Misra A; Vaidya M; Dasgupta J; Chadha DS
PLoS One; 2013; 8(1):e49286. PubMed ID: 23326306
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia-A Prospective, Interventional, Pilot Study.
Rajesh NA; Drishya L; Ambati MMR; Narayanan AL; Alex M; R KK; Abraham JJ; Vijayakumar TM
J Clin Exp Hepatol; 2022; 12(1):61-67. PubMed ID: 35068786
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients.
Belinchón-Romero I; Bellot P; Romero-Pérez D; Herraiz-Romero I; Marco F; Frances R; Ramos-Rincón JM
Sci Rep; 2021 Apr; 11(1):8593. PubMed ID: 33883616
[TBL] [Abstract][Full Text] [Related]
18. Study and Comparison of Metabolic Profile of Lean and Obese Subjects with Non Alcoholic Fatty Liver Disease.
Shah P; Rathi P; Mandot A; Pal A; Ahire D
J Assoc Physicians India; 2020 Aug; 68(8):51-54. PubMed ID: 32738842
[TBL] [Abstract][Full Text] [Related]
19. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
Nikbaf-Shandiz M; Tutunchi H; Khoshbaten M; Nazari Bonab H; Ebrahimi-Mameghani M
Food Funct; 2022 Nov; 13(22):11568-11578. PubMed ID: 36263703
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
